nav-left cat-right
cat-right

NIH “Roadmap” Grants Will Establish Nine Scree...

The National Institutes of Health (NIH) today announced it is awarding $88.9 million in grants to nine institutions over three years to establish a collaborative research network that will use high-tech screening methods to identify small molecules that can be used as research tools. Small molecules have great potential to help scientists in their efforts to learn more about key biological processes involved in human health...

Southern Research Receives National Grant for Drug...

BIRMINGHAM, Ala., June 17 /PRNewswire/ — The National Institutes of Health (NIH) announced $88.9 million in grant awards to establish a collaborative research network that will use robotic high-throughput screening methods to identify small molecule probes as tools for new drug discovery. Southern Research was one of nine U.S. research organizations selected to participate in the NIH Roadmap Molecular Libraries...

Scripps gets NIH $10.4-million grant

By wire services Published June 17, 2005 Scripps Research Institute has been awarded a $10.4-million grant from the National Institutes of Health to establish a molecular screening center that will help translate basic biomedical discoveries more quickly into medical applications. Chemical compound development will take place at Scripps’ La Jolla, Calif., campus while high-throughput screening of those compounds to find...

National Institutes of Health Awards $11.9 M to Th...

SAN DIEGO, Calif., June 17 (AScribe Newswire) — The Burnham Institute has been selected by the National Institutes of Health (NIH) as one of nine national centers for high-throughput chemical compound screening, known collectively as “The Molecular Libraries Screening Centers Network”, that will comprise the world’s largest collaborative network focused on drug discovery. Dr. John C. Reed, President...

GPC Biotech and Ingenium receive joint drug discov...

GPC Biotech, a public company, is primarily focused on the research and development of cancer drugs. Ingenium is a private company focused on the treatment of pain. The collaboration sees both companies working towards establishing proof of concept for the activity of specific kinase inhibitors using animal models, and will cover several disease areas. The goal is to rapidly advance novel drug targets towards clinical...

Dr. Chris Lipinski (TB Alliance) Honored by Americ...

Dr. Chris Lipinski (TB Alliance) Honored by American Chemical Society for Rule of Five Dr. Christopher Lipinski, member of the TB Alliance Scientific Advisory Committee and a retired Senior Research Fellow at Pfizer Global R&D Groton New London labs, has been honored for his groundbreaking “Rule of Five” by the American Chemical Society. On August 23rd, the ACS announced that Dr. Lipinski is the recipient of...
Page 9 of 9« First...56789